Cartilago/Mandragora comp. Soluzione iniettabile (s. c.)

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

antimonit (HAB) D5 (HAB 40b), argentum metallicum (HAB) D7 aquos., betula pendula ferm 34e (HAB) D4, cartilago articularis bovis Gl D7 (HAB 41b), mandragora officinarum e radice rec. ferm 34d D4 (HAB 34d), natrium

MAH:

WALA Schweiz AG

INN:

antimonit (HAB) D5 (HAB 40b), argentum metallicum (HAB) D7 aquos., betula pendula ferm 34e (HAB) D4, cartilago articularis bovis Gl D7 (HAB 41b), mandragora officinarum e radice rec. ferm 34d D4 (HAB 34d), natrium

pharmaceutical_form:

Soluzione iniettabile (s. c.)

composition:

antimonit (HAB) D5 (HAB 40b) 100 mg, argentum metallicum (HAB) D7 aquos. 100 mg, betula pendula ferm 34e (HAB) D4 100 mg, cartilago articularis bovis Gl D7 (HAB 41b) 100 mg, mandragora officinarum e radice rec. ferm 34d D4 (HAB 34d) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, lactosum monohydricum, pro vitro 1 ml corresp. natrium 3.11 mg.

class:

B

therapeutic_group:

Antroposofici

therapeutic_area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

authorization_status:

zugelassen

authorization_date:

2014-01-29